Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19

Clinical studies have identified a cytokine storm in the third stage of disease progression in critical ill patients with coronavirus disease 2019 (COVID-19). Hence, effectively suppressing the uncontrolled immune response of the host towards the invaded viruses in a cytokine storm is a critical ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Shikha, Saxena, Bhagawati, Mehta, Priti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846241/
https://www.ncbi.nlm.nih.gov/pubmed/33553708
http://dx.doi.org/10.1016/j.heliyon.2021.e06158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846241/
https://www.ncbi.nlm.nih.gov/pubmed/33553708
http://dx.doi.org/10.1016/j.heliyon.2021.e06158

Ejemplares similares